Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
作者： Yun-Fei Xu , Xiao-Qing Yang , Xiao-Fei Lu , Sen Guo , Yi Liu
DOI: 10.1016/J.BBRC.2014.02.050
关键词:
摘要: … (A) AP24534 IC50 on the proliferation of FGFR4-expressing 293 cells. After transfection with FLAG-FGFR4 for 48 h and starvation in serum free medium overnight, 293 cells were …
osti.gov
sci-hub.se 参考文章(26)
Rimm Dl, Costa J, Camp Rl, Charette La, Reiss M, Olsen Da, Tissue microarray: a new technology for amplification of tissue resources. Cancer Journal. ,vol. 7, pp. 24- 31 ,(2001)
Olivier Farges, David Fuks, Yves‐Patrice Le Treut, Daniel Azoulay, Alexis Laurent, Philippe Bachellier, Gennaro Nuzzo, Jacques Belghiti, François René Pruvot, Jean Marc Regimbeau, None, AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer. ,vol. 117, pp. 2170- 2177 ,(2011) , 10.1002/CNCR.25712
Vincent T. Bicocca, Bill H. Chang, Behzad Kharabi Masouleh, Markus Muschen, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner, Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia Cancer Cell. ,vol. 22, pp. 656- 667 ,(2012) , 10.1016/J.CCR.2012.08.027
Nicholas Turner, Richard Grose, Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer. ,vol. 10, pp. 116- 129 ,(2010) , 10.1038/NRC2780
Chandra N. Prasad, Katherine S. Virgo, Frank E. Johnson, Terence P. Wade, Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987–1991 Journal of Surgical Oncology. ,vol. 64, pp. 242- 245 ,(1997) , 10.1002/(SICI)1096-9098(199703)64:3<242::AID-JSO12>3.0.CO;2-6
Valéria Cristina da Costa Andrade, Orlando Parise, Cora Pereira Hors, Poliana Cristina de Melo Martins, Alexandre Pacheco Silva, Bernardo Garicochea, The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma Experimental and Molecular Pathology. ,vol. 82, pp. 53- 57 ,(2007) , 10.1016/J.YEXMP.2006.05.003
Victoria Knights, Simon J. Cook, De-regulated FGF receptors as therapeutic targets in cancer. Pharmacology & Therapeutics. ,vol. 125, pp. 105- 117 ,(2010) , 10.1016/J.PHARMTHERA.2009.10.001
Michelle L DeOliveira, Steven C Cunningham, John L Cameron, Farin Kamangar, Jordan M Winter, Keith D Lillemoe, Michael A Choti, Charles J Yeo, Richard D Schulick, None, Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution Annals of Surgery. ,vol. 245, pp. 755- 762 ,(2007) , 10.1097/01.SLA.0000251366.62632.D3
Shanglei Ning, Sen Guo, Jianjun Xie, Yunfei Xu, Xiaofei Lu, Yuxin Chen, TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma. Journal of Gastrointestinal Surgery. ,vol. 17, pp. 360- 368 ,(2013) , 10.1007/S11605-012-2105-1
Yan Wei Ye, Ye Zhou, Lin Yuan, Chun Meng Wang, Chun Yan Du, Xiao Yan Zhou, Bi Qiang Zheng, Xi Cao, Meng Hong Sun, Hong Fu, Ying Qiang Shi, Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression. Cancer. ,vol. 117, pp. 5304- 5313 ,(2011) , 10.1002/CNCR.26207